17-alpha-hydroxyprogesterone has been researched along with Electrolytes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gangodkar, P; Khadilkar, A; Khadilkar, V; Maheshwari, A | 1 |
| Cavarzere, P; Dechaux, M; Elie, C; Flechtner, I; Morel, Y; Polak, M; Samara-Boustani, D; Tardy, V | 1 |
| White, PC | 1 |
1 review(s) available for 17-alpha-hydroxyprogesterone and Electrolytes
| Article | Year |
|---|---|
Neonatal screening for congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Electrolytes; Humans; Infant, Newborn; Neonatal Screening | 2009 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Electrolytes
| Article | Year |
|---|---|
Long-term Growth in Congenital Adrenal Hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Body Height; Body Mass Index; Child; Electrolytes; Female; Fludrocortisone; Growth; Humans; Hydrocortisone; India; Male; Progesterone; Retrospective Studies; Sex Factors; Sexual Maturation; Testosterone; Treatment Outcome | 2019 |
Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Dehydroepiandrosterone Sulfate; DNA; Electrolytes; False Positive Reactions; Female; Humans; Hydrocortisone; Infant, Newborn; Male; Neonatal Screening; Renin; Retrospective Studies; Steroid 21-Hydroxylase; Testosterone | 2009 |